LOVENBERG WALTER M PHD 4
4 · OSI PHARMACEUTICALS INC · Filed Jan 5, 2005
Insider Transaction Report
Form 4
LOVENBERG WALTER M PHD
Director
Transactions
- Sale
Common Stock
2005-01-03$73.52/sh−188$13,822→ 9,531 total - Sale
Common Stock
2005-01-03$74.10/sh−8$593→ 8,733 total - Sale
Common Stock
2005-01-03$74.42/sh−29$2,158→ 8,654 total - Sale
Common Stock
2005-01-03$73.62/sh−4$294→ 9,087 total - Sale
Common Stock
2005-01-03$74.41/sh−21$1,563→ 8,683 total - Exercise/Conversion
Common Stock
2005-01-03$9.25/sh+1,667$15,420→ 9,719 total - Sale
Common Stock
2005-01-03$73.53/sh−427$31,397→ 9,104 total - Sale
Common Stock
2005-01-03$73.65/sh−209$15,393→ 8,878 total - Sale
Common Stock
2005-01-03$74.40/sh−25$1,860→ 8,704 total - Sale
Common Stock
2005-01-03$74.50/sh−42$3,129→ 8,061 total - Sale
Common Stock
2005-01-03$73.60/sh−13$957→ 9,091 total - Sale
Common Stock
2005-01-03$74.60/sh−9$671→ 8,052 total - Sale
Common Stock
2005-01-03$74.05/sh−33$2,444→ 8,741 total - Sale
Common Stock
2005-01-03$73.95/sh−104$7,691→ 8,774 total - Sale
Common Stock
2005-01-03$74.47/sh−547$40,735→ 8,103 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-01-03−1,667→ 13,332 totalExercise: $9.25From: 1997-03-25Exp: 2006-03-24→ Common Stock (1,667 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.